Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)

Clinical trial NCT01190254 · COMPLETED

Trial details

NCT number: NCT01190254
Sponsor: Organon and Co
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia, Paranoid Schizophrenia, Disorganized Schizophrenia, Undifferentiated

Start date: 2010-09-28
Primary completion: 2013-03-10
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.